Thinking about what I can learn from CSL, in light of recent events.
Briefly, I first bought a medium-sized parcel in 2014 for around $76. I have held those ever since, although I have bought and sold moderate amounts in various different accounts at different times.
Looking back over the whole timeframe, I think my big mistake was not selling out when the price got clearly beyond the fundamentals. The reason that I am particularly annoyed with myself is that I more or less knew it. I can remember looking at CSL in late 2019, after the share price had run hard. It was on a PE of something like 50. I didn't know exactly how things were going to play out, but I clearly knew that the price was expensive and implied ongoing high growth rates well into the future. I also knew that CSL was getting very large and that at some stage the exponential growth from extracting substances from plasma would moderate, as the company matured.

So why didn't I act? A number of reasons. Firstly, cognitive bias. I had a psychological attachment to the stock, because it had made me a lot of money. Secondly, tax implications: there would have obviously been a considerable CGT to pay. Thirdly (probably the biggest factor), I allowed myself to be influenced by a lot of stuff I was reading in the financial press and online. Warren Buffett "Our favourite holding period is forever". Any number of people urging "Never sell quality compounders".
Intelligent Investor (which I generally respect and have been subscribed to for many years) published a "Never sell" article in October 2019. Ironically right at the time I should have been selling CSL (and several of the other companies on the list):


I don't have the time to run the figures, but I'm pretty certain that list would have underperformed the market fairly dramatically.
So what have I learnt?
I think all of us like to make life simple. We all look for rules and patterns that we can apply, based on what we have observed previously. This is the underlying error.
Back in 2019, Quality compounders had experienced a long period of outperformance. People naturally tried to turn this into a simple rule. "All you have to do is buy and hold the right quality companies that can compound earnings". Sounds very attractive, doesn't it. I bought into it.
The sharemarket is a place of almost infinite complexity. Trying to make simple rules is almost never going to work. Definitely not in the long term
The harsh reality is that every single thing that we own needs to be continuously re-evaluated on a regular basis. When we have reasonable certainty that valuation is not aligned with value, we should act.
There is no "Never Sell" list. There are no shortcuts or free lunches.
That is what I have learnt from CSL
[At the cost of the value of my shares halving since I should have sold in 2019, plus over 6 years of opportunity cost]